Omalizumab Injection
Sponsors
Rigshospitalet, Denmark, Carsten Bindslev-Jensen, Kashiv BioSciences, LLC, National Jewish Health, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Conditions
AsthmaChronic Idiopathic UrticariaFood AllergiesFood AllergyFood Allergy in ChildrenInfertility, Female
Phase 2
Phase 3
Phase 4
Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana).
TerminatedNCT03964051
Start: 2019-07-01End: 2020-12-21Updated: 2023-12-11
Effect of Omalizumab in the Skin of Food Allergy Patients
RecruitingNCT06618963
Start: 2024-10-01End: 2026-12-31Target: 40Updated: 2025-05-02